Drugs / V540A-3
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT07224477 | Jul 2026 → Apr 2028 expected | — | Merck Sharp & Dohme LLC | Not yet recruiting | No outcome recorded |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | V540A-3 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT07224477 ↗ |